BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38043008)

  • 1. Correlation between IL3 signaling pathway-related genes and immune checkpoint inhibitor efficacy in patients with renal cell carcinoma.
    Hou S; Gu T; Shi Y; Huang Y; Yao J; Luo P; Cao M; Zhang J; Lin A; Zhu W
    Cancer Biomark; 2023; 38(4):489-504. PubMed ID: 38043008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
    Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
    Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma.
    Zhang G; Chen X; Fang J; Tai P; Chen A; Cao K
    Front Immunol; 2022; 13():954440. PubMed ID: 36059510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New Signature That Predicts Progression-Free Survival of Clear Cell Renal Cell Carcinoma with Anti-PD-1 Therapy.
    Lin J; Cai Y; Ma Y; Pan J; Wang Z; Zhang J; Liu Y; Zhao Z
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Genomic and Transcriptome Analyses to Identify the Role of the Oxidative Stress Pathway in Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance.
    Che X; Qi X; Xu Y; Wang Q; Wu G
    Oxid Med Cell Longev; 2021; 2021():5561124. PubMed ID: 34721758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of the relation to tumor immune microenvironment and predicted value of Stonin1 gene for immune checkpoint blockage and targeted treatment in kidney renal clear cell carcinoma.
    Zheng A; Bai J; Ha Y; Yu Y; Fan Y; Liang M; Lu Y; Shen Z; Luo B; Jie W
    BMC Cancer; 2023 Feb; 23(1):135. PubMed ID: 36759775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma.
    Zheng W; Zhang S; Guo H; Chen X; Huang Z; Jiang S; Li M
    Cell Commun Signal; 2021 Mar; 19(1):39. PubMed ID: 33761933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role.
    Zhong S; Chen S; Lin H; Luo Y; He J
    BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene set enrichment analysis identifies immune subtypes of kidney renal clear cell carcinoma with significantly different molecular and clinical properties.
    Chen Z; Cao W; Luo J; Abdelrahman Z; Lu Q; Wang H; Wang X
    Front Immunol; 2023; 14():1191365. PubMed ID: 37426638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening Novel Drug Candidates for Kidney Renal Clear Cell Carcinoma Treatment: A Study on Differentially Expressed Genes through the Connectivity Map Database.
    Gao B; Wang L; Zhang N; Han M; Zhang Y; Liu H; Sun D; Liu Y
    Kidney Blood Press Res; 2021; 46(6):702-713. PubMed ID: 34818247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel prognostic signature of chemokines for survival and immune infiltration in kidney renal clear cell carcinoma.
    Weng J; Huang Z; Li Q; Huang Y; Chen S
    Int J Med Sci; 2023; 20(8):1046-1059. PubMed ID: 37484803
    [No Abstract]   [Full Text] [Related]  

  • 13. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
    Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
    Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
    Xing Q; Ji C; Zhu B; Cong R; Wang Y
    Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma.
    Bao Y; Jiang A; Dong K; Gan X; Gong W; Wu Z; Liu B; Bao Y; Wang J; Wang L
    Int J Biol Sci; 2021; 17(12):3158-3172. PubMed ID: 34421357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma.
    Chen CC; Chu PY; Lin HY
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of a novel signature based on macrophage marker genes for predicting prognosis and drug response in kidney renal clear cell carcinoma by integrated analysis of single cell and bulk RNA sequencing.
    Chen X; Zhang Z; Qin Z; Zhu X; Wang K; Kang L; Li C; Wang H
    Aging (Albany NY); 2024 Mar; 16(6):5676-5702. PubMed ID: 38517387
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Klümper N; Ralser DJ; Bawden EG; Landsberg J; Zarbl R; Kristiansen G; Toma M; Ritter M; Hölzel M; Ellinger J; Dietrich D
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32234847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of NF-κB pathway in kidney renal clear cell carcinoma and its potential therapeutic implications.
    Sun J; Chen F; Wu G
    Aging (Albany NY); 2023 Oct; 15(20):11313-11330. PubMed ID: 37847185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated ADH5 expression suggested better prognosis in kidney renal clear cell carcinoma (KIRC) and related to immunity through single-cell and bulk RNA-sequencing.
    Sun J; Zhang X; Wu F; Zhu B; Xie H
    BMC Urol; 2024 Apr; 24(1):84. PubMed ID: 38600527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.